UCAR Logo

UCAR

ALUCR | PA

Overview

Corporate Details

ISIN(s):
FR0011070457
LEI:
969500K8EPT7JBE7FP45
Country:
France
Address:
10 RUE LOUIS PASTEUR, 92100 BOULOGNE-BILLANCOURT
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

The University Corporation for Atmospheric Research (UCAR) is a nonprofit consortium of over 100 member universities and colleges focused on research and training in atmospheric and Earth system sciences. Its primary role is managing the National Science Foundation National Center for Atmospheric Research (NSF NCAR), a federally funded research and development center. UCAR provides the scientific community with access to advanced research facilities, observing and computing resources, data services, and educational programs. The organization fosters collaboration between academia, government, and the private sector to accelerate scientific discovery in geosciences.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for UCAR. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-07-08 16:50
Delisting Announcement
COMMUNIQUE RELATIF A LA MISE EN ŒUVRE DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS…
French 162.7 KB
2022-07-07 10:16
Major Shareholding Notification
Franchissement de seuils
French 201.7 KB
2022-07-05 15:13
Declaration of Voting Results & Voting Rights Announcements
UCAR - Nombre d'actions et de droits de vote au 30 06 2022
French 183.0 KB
2022-06-22 09:02
M&A Activity
MISE A DISPOSITION DE LA NOTE D’INFORMATION EN REPONSE ET DU DOCUMENT « AUTRES …
French 200.2 KB
2022-06-22 09:00
M&A Activity
MISE A DISPOSITION DE LA NOTE D’INFORMATION ET DES INFORMATIONS RELATIVES AUX C…
French 121.8 KB
2022-06-02 09:18
Declaration of Voting Results & Voting Rights Announcements
UCAR - Nombre d'actions et de droits de vote au 31 mai 2022
French 182.3 KB
2022-05-25 16:50
Pre-Annual General Meeting Information
COMMUNIQUE RELATIF AU DEPOT D’UN PROJET DE NOTE EN REPONSE AU PROJET D’OFFRE PU…
French 516.9 KB
2022-05-23 17:50
M&A Activity
UCAR - Accord avec FRANCE PARE BRISE
French 314.5 KB
2022-05-23 10:52
Declaration of Voting Results & Voting Rights Announcements
Franchissement de seuils
French 201.9 KB
2022-05-23 10:50
Major Shareholding Notification
Franchissement de seuils
French 199.0 KB
2022-05-17 19:00
M&A Activity
UCAR - Réalisation de l’acquisition par GOA LCD d’un bloc de contrôle au capita…
French 221.9 KB
2022-05-11 14:55
Declaration of Voting Results & Voting Rights Announcements
UCAR - Nombre d'actions et de droits de vote au 30 avril 2022
French 180.7 KB
2022-04-11 15:30
M&A Activity
UCAR – rapprochement avec le Groupe Cosmobilis – Projet d’OPAS visant les actio…
French 348.7 KB
2022-04-08 09:00
Delisting Announcement
UCAR - Suspension de cours
French 170.0 KB
2022-04-07 21:05
Earnings Release
UCAR - Résultats 2021
French 227.0 KB

Automate Your Workflow. Get a real-time feed of all UCAR filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for UCAR via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NextCell Pharma AB Logo
Develops MSC therapies for autoimmune diseases and offers private stem cell banking services.
Sweden NXTCL
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions for pharma licensing.
France ALNFL
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
Nortem BioGroup Logo
Biotech R&D of natural products for consumer health, home, and animal nutrition.
Spain MLBIO
NRGene Technologies Ltd. Logo
AI genomics software accelerating plant & animal breeding for the agriculture industry.
Israel NRGN
NUFORMIX PLC Logo
A pharma firm repurposing drugs for fibrosis and oncology via proprietary cocrystal technology.
United Kingdom NFX
Nykode Therapeutics ASA Logo
Developing targeted immunotherapies and vaccines for cancer and infectious diseases.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive drugs for sight-threatening eye diseases.
Switzerland OCS
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC